Where will synthetic biology take cell & gene therapy?

Cell & Gene Therapy Insights 2019; 5(12), 1549-1555.


Published: 28 November 2019
Timothy Lu

Tim Lu is a pioneer in synthetic biology and an Associate Professor at MIT. He received his MD/PhD from MIT and Harvard. He is a co-founder of Synlogic (NASDAQ: SYBX), Tango Therapeutics, Sample6, Eligo, BiomX, and Engine Biosciences. He has received the NIH New Innovator Award, the US President Early Career Award for Scientists and Engineers, MIT Technology Review’s TR35, Navy and Army Young Investigator Prizes, and others.